MedPath

Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland

Completed
Conditions
Postmenopausal Osteoporosis
Spinal Fractures
Registration Number
NCT02234414
Lead Sponsor
Prof. Dr. med. Kurt Lippuner
Brief Summary

In Switzerland, the prevalence of vertebral fractures in community- dwelling women is unknown and the published data from the Swiss hospitals statistics represent only the tip of the iceberg. In addition, the percentages of women correctly identified with vertebral fractures due to osteoporosis and the treatment rate of these women with a drug proven to reduce the risk of further fractures are unknown. Furthermore, it is not known whether the prevalence of vertebral fractures differs between urban and rural areas or between mountain areas and plain country, e.g. due to possible differences in sun exposure (vitamin D production) and/ or in physical activity and/ or dietary habits.

Clinical signs and symptoms leading to the suspicion of vertebral fracture(s) lack either sensitivity (wall-occiput distance) or specificity (rib-pelvis distance). Whether a combination of both would improve sensitivity and specificity is unknown.

The gold standard for the diagnosis of vertebral fracture relies on antero-posterior and lateral X-Rays of the thoracic and lumbar spine. Despite standardization of X-Ray readings, a retrospective study of hospitalized elderly patients has shown that as many as 50% of the radiographic reports failed to note the presence of moderate to severe vertebral fractures. In a primary care setting, fewer than 2% of the women received diagnoses of osteoporosis or vertebral fracture, although expected prevalence is 20% to 30% and appropriate drug treatment was offered to only 36% of the diagnosed patients.

The recent availability of software for vertebral fracture assessment (VFA) coupled to DXA measurements allows for the detection of vertebral deformities, which is critical for management of osteoporosis, as the existence of such deformities substantially increases the risk of subsequent fracture. Recently published results show that VFA allows the diagnosis of a vertebral fracture. The sensitivity of VFA for detection of vertebral fractures compared to expert radiologist reading of X-ray is excellent for grade 2 and 3 fractures, ranging between 90-94%.

Detailed Description

Examinations

* Community-dwelling women from a random sample (address lists may be chosen from public and/ or private providers)

* Aged 65-79 yrs

* Written informed consent

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
303
Inclusion Criteria
  • Community-dwelling women from a random sample (address lists may be chosen from public and/ or private providers)
  • Aged 65-79 yrs
  • Written informed consent
Exclusion Criteria
  • Patients who underwent spine surgery
  • Not willing or not able to sign informed consent
  • In patients not willing or not able to participate, the reason for denial will be recorded for future evaluation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of vertebral fractures in community dwelling Swiss women aged 65-79 yearsat the only study visit
Secondary Outcome Measures
NameTimeMethod
Assessment of the differences between these women and those who are either not correctly diagnosed or not correctly treatedat the only study visit
Specificity, sensitivity, positive predictive value and negative predictive value for the prediction of underlying vertebral fracture of selected risk factors, clinical signs and vitamin D level, alone or in combinationat the only study visit
Assessment of the percentage of women correctly identified with a vertebral fracture and adequately treated for underlying osteoporosis andat the only study visit

Trial Locations

Locations (3)

Hochgebirgsklinik Davos

🇨🇭

Davos-Wolfgang, Switzerland

Kantonsspital Olten

🇨🇭

Olten, Switzerland

HFR Tafers

🇨🇭

Tafers, Switzerland

© Copyright 2025. All Rights Reserved by MedPath